Botulinum neurotoxin type A combined with functional electrical stimulation for upper-limb poststroke spasticity with pain

IF 0.6 Q4 CLINICAL NEUROLOGY

Future Neurology Pub Date : 2018-11-01 DOI:10.2217/FNL-2018-0020

A. Nikbakht, A. Karshenas, P. Gazerani

引用次数: 1

Abstract

Stroke is a complicated condition that leaves stroke survivors with prolonged disability. Common poststroke conditions are spasticity and pain, which directly affect daily activities and quality of life in these patients. Botulinum neurotoxin type A is an effective and well-tolerated treatment option for upper-limb spasticity. It reduces muscle tone and improves basic upper-limb activities. Functional electrical stimulation is also used widely as a therapeutic modality in the upper-limb muscle rehabilitation. Here, we present a case in which Botulinum neurotoxin type A injections combined with functional electrical stimulation were applied for upper-limb spasticity accompanied with pain in a poststroke patient.

查看原文本刊更多论文

A型肉毒毒素联合功能性电刺激治疗脑卒中后上肢痉挛伴疼痛

中风是一种复杂的情况，会使中风幸存者长期残疾。常见的卒中后症状是痉挛和疼痛，这直接影响这些患者的日常活动和生活质量。A型肉毒毒素是治疗上肢痉挛的有效且耐受性良好的治疗选择。它可以降低肌肉张力，改善上肢的基本活动。功能性电刺激也被广泛用作上肢肌肉康复的一种治疗方式。在这里，我们介绍了一个案例，其中a型肉毒毒素注射结合功能性电刺激用于治疗中风后患者的上肢痉挛伴疼痛。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future Neurology CLINICAL NEUROLOGY-

CiteScore

2.10

自引率

0.00%

发文量

期刊介绍： The neurological landscape is changing rapidly. From the technological perspective, advanced molecular approaches and imaging modalities have greatly increased our understanding of neurological disease, with enhanced prospects for effective treatments in common but very serious disorders such as stroke, epilepsy, multiple sclerosis and Parkinson’s disease. Nevertheless, at the same time, the healthcare community is increasingly challenged by the rise in neurodegenerative diseases consequent upon demographic changes in developed countries.